This meeting took place in 2020
Here are the related meetings in 2021:
Tuberculosis: Science Aimed at Ending the Epidemic (EK10)
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Tuberculosis: Immunity and Immune Evasion (A2)
Organizer(s) Joel Ernst, Jennifer Philips and Daniel L. Barber
January 16—20, 2020
Eldorado Hotel & Spa • Santa Fe, NM USA
Discounted Abstract Deadline: Sep 24, 2019
Abstract Deadline: Oct 16, 2019
Scholarship Deadline: Sep 24, 2019
Discounted Registration Deadline: Nov 19, 2019
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation
Summary of Meeting:
Tuberculosis remains the most common fatal infectious disease worldwide due to the absence of a sufficiently effective vaccine. Two critical barriers to the development of an effective TB vaccine are the incomplete understanding of the mechanisms of protective immunity to TB, and of the mechanisms of immune evasion by M. tuberculosis. The interactions among speakers and attendees at this conference will promote collaborations between scientists with complementary expertise who work in geographically distinct institutions, including those in high TB burden regions. This conference will present new findings on mechanisms of protective immunity to M. tuberculosis, and promote dialogue between immunologists and scientists in different areas of expertise to fill gaps in knowledge. Participants will also discuss advances in TB vaccine development and vaccine immunology. Finally, this conference will cover advances in other fields of immunology and other infectious diseases characterized by pathogen persistence, which will help to inform development of effective TB vaccines.
View Meeting Program
Tuberculosis remains the most common fatal infectious disease worldwide due to the absence of a sufficiently effective vaccine. Two critical barriers to the development of an effective TB vaccine are the incomplete understanding of the mechanisms of protective immunity to TB, and of the mechanisms of immune evasion by M. tuberculosis. The interactions among speakers and attendees at this conference will promote collaborations between scientists with complementary expertise who work in geographically distinct institutions, including those in high TB burden regions. This conference will present new findings on mechanisms of protective immunity to M. tuberculosis, and promote dialogue between immunologists and scientists in different areas of expertise to fill gaps in knowledge. Participants will also discuss advances in TB vaccine development and vaccine immunology. Finally, this conference will cover advances in other fields of immunology and other infectious diseases characterized by pathogen persistence, which will help to inform development of effective TB vaccines.
View Meeting Program
Scholarships/Awards
Keystone Symposia Future of Science Fund Scholarship Recipients
Shi-Hsia Hwa
Africa Health Research Institute, South Africa
National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients
Susana Benet
Irsicaixa, Spain
Robyn Emery
University of Washington, USA
Megan Files
University of Texas Medical Branch, USA
Ben Gern
Seattle Children's Research Institute, USA
Rujapak Sutiwisesak
Ubon Ratchathani University, Thailand
Keystone Symposia Global Health Travel Award Recipients, funded by the Bill & Melinda Gates Foundation
Kedir Abdella Abdulsemed
Jimma University, Ethiopia
Mohamed Ahmed
Africa Health Research Institute, South Africa
Diana Ayinpokbila Akila
University of Health and Allied Sciences, Ghana
Victor Oluwatoyin Akinseye
Augustine University Ilara-Epe, Nigeria
Funmilola Abidemi Ayeni
University of Ibadan, Nigeria
Debapriya Bhattacharya
Siksha O Anusandhan University, India
Fatoumatta Darboe
Medical Research Council, The Gambia Unit, Gambia
Osagie Aiwerioghene Eribo
Stellenbosch University, South Africa
Samreen Fatima
Jawaharlal Nehru University, India
Elizabeth Andrea Garcia
National Institute of Agricultural Technology, Argentina
Lona Gcanga
University of Cape Town, South Africa
Melanie Genoula
Instituto de Medicina Experimental CONICET-ANM, Argentina
Jariya Hanthamrongwit
Mahidol University, Thailand
Neharika Jain
International Centre for Genetic Engineering and Biotechnology, India
Mulualem Tadesse Jano
Jimma University, Ethiopia
Rogers Eliphaz Kamulegeya
Makerere University, Uganda
Chetkar Chandra Keshavam
University of Delhi, India
Khanyisile Kgoadi
University of Cape Town, South Africa
Jeremiah Khayumbi
CDC Centre for Global Health Research/Maseno University, Kenya
Carine Kunsevi-Kilola
Stellenbosch University, South Africa
Mohau Steven Makatsa
University of Cape Town, South Africa
Masilo Charles Manyelo
Stellenbosch University, South Africa
José Luis Marín
Instituto de Medicina Experimental IMEX-CONICET, Argentina
Michele Ann Miller
Stellenbosch University, South Africa
Ravi Prasad Mukku
Center for Cellular and Molecular Biology, India
Lucy Mupfumi
Botswana Harvard AIDS Institute, Botswana
Rehema Mukami Mwaniki
Centers for Disease Control, Kenya
Mariam Nakabuye
Makerere University, Uganda
Anna Ritah Namuganga
Joint Clinical Research Centre, Uganda
Rofhiwa Nesamari
University of Cape Town, South Africa
Caleb Nwongbouwoh Muefong
Medical Research Council Unit-The Gambia, Gambia
Rym Ouni
Institut Pasteur de Tunis, Tunisia
Nagender Rao Rameshwaram
Centre for DNA Fingerprinting & Diagnostics, India
ANSHU RANI
INDIAN INSTITUTE OF TECHNOLOGY DELHI, India
Sadhna Sharma
Miranda House, University of Delhi, India
Tarina Sharma
Indian Institute of Technology Delhi, India
Adriano Q. Silva
Instituto Gonçalo Moniz / Fiocruz, Brazil
Patrick Fernandes da Silva
School of Medicine of Ribeirão Preto, Brazil
Esther Uwimaana
Makerere University Lung Institute, Uganda
Lin Wang
Shanghai Pulmonary Hospital, China